Form 8-K - Current report:
SEC Accession No. 0001140361-22-008622
Filing Date
2022-03-09
Accepted
2022-03-09 16:21:21
Documents
17
Period of Report
2022-03-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10034972_8k.htm   iXBRL 8-K 40418
2 EXHIBIT 10.1 brhc10034972_ex10-1.htm EX-10.1 244283
3 EXHIBIT 10.2 brhc10034972_ex10-2.htm EX-10.2 105286
4 EXHIBIT 10.3 brhc10034972_ex10-3.htm EX-10.3 107870
5 EXHIBIT 10.4 brhc10034972_ex10-4.htm EX-10.4 166038
6 EXHIBIT 99.1 brhc10034972_ex99-1.htm EX-99.1 10361
  Complete submission text file 0001140361-22-008622.txt   963866

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA btx-20220306.xsd EX-101.SCH 3929
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE btx-20220306_lab.xml EX-101.LAB 22544
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE btx-20220306_pre.xml EX-101.PRE 16047
11 EXTRACTED XBRL INSTANCE DOCUMENT brhc10034972_8k_htm.xml XML 4246
Mailing Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220
Business Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220 (212) 582-1199
Brooklyn ImmunoTherapeutics, Inc. (Filer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-11460 | Film No.: 22725630
SIC: 2834 Pharmaceutical Preparations